Intuitive Surgical, Inc. $ISRG Stock Purchased by Private Wealth Asset Management LLC

Private Wealth Asset Management LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 558.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 2,455 shares of the medical equipment provider’s stock after acquiring an additional 2,082 shares during the period. Private Wealth Asset Management LLC’s holdings in Intuitive Surgical were worth $998,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Dogwood Wealth Management LLC increased its stake in shares of Intuitive Surgical by 178.3% during the third quarter. Dogwood Wealth Management LLC now owns 64 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 41 shares during the period. North Point Portfolio Managers Corp OH acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $27,000. John Boyer Inc. acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $27,000. Compass Wealth Management LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $29,000. Finally, Compass Financial Management LLC purchased a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Patricia Wadors sold 1,078 shares of the stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $478,416.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig Barratt sold 1,150 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the sale, the director directly owned 1,150 shares of the company’s stock, valued at approximately $529,000. This represents a 50.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 39,363 shares of company stock worth $17,738,749. Company insiders own 0.60% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are a few of the latest headlines about ISRG:

  • Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
  • Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
  • Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $399.06 on Friday. The stock has a market cap of $138.33 billion, a price-to-earnings ratio of 48.25, a price-to-earnings-growth ratio of 2.75 and a beta of 1.45. The business’s 50-day simple moving average is $423.51 and its 200 day simple moving average is $427.91. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the company earned $2.40 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ISRG. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Tuesday. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. Mizuho lowered their target price on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 21st. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, UBS Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $495.90.

Get Our Latest Stock Report on ISRG

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.